Quality of life of elderly people on warfarin for atrial fibrillation

Age and Ageing

Volumn 38, Issue 6, 2009, Pages 751-754

  Das, Abhay K ^a   Ahmed, Ashraf ^b   Corrado, Oliver J ^c   West, Robert M ^b  

^a Pontefract General Infirmary   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

AGE DISTRIBUTION; AGED; AGING; ANTICOAGULANT THERAPY; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PHYSICAL CAPACITY; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 12; THROMBOSIS PREVENTION; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HEALTH STATUS; HUMANS; MALE; MATCHED-PAIR ANALYSIS; QUALITY OF LIFE; STROKE; WARFARIN;

EID: 70350642111     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afp158     Document Type: Letter

References (21)

1. Marini C, De Santis F, Sacco S et al. Contribution of atrial fibrillation to incidence and outcome of ischaemic stroke: Results from a population based study. Stroke 2005; 35: 1115-9.
2. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Arch Intern Med 1995; 155: 469-73.
3. Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999; 131: 492-501.
4. Hart RG, Pearce LA, Koudstaal PJ. Transient ischaemic attacks in patients with atrial fibrillation: Implications for secondary prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial. Stroke 2004; 35: 948-51.
5. O'Donnell M, Oczkowski W, Fang J et al. Influence of preadmission antithrombotic therapy on stroke severity in patients with atrial fibrillation: An observational study. Lancet Neurol 2006; 5: 749-54.
6. Albers GW, Dalen JE, Laupacis A et al. Antithrombotic therapy in atrial fibrillation. Chest 2001; 119(Suppl): 194s-206s.
7. Gage BF, Waterman AD, Shannon W et al. Validation of clinical classification schemes for predicting stroke. Results from the national registry of atrial fibrillation. JAMA 2001; 285: 2864-70.
8. Wheeldon NM, Taylor DI, Anagnostou E, Cook D, Wales C, Oakley GDG. Screening for atrial fibrillation in primary care. Heart 1998; 79: 50-5.
9. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of the rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002; 347: 1834-40.
10. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998; 352: 1167-71.
11. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett ELC. Physician attitude s about anticoagulation for non-valvular atrial fibrillation in the elderly. Arch Intern Med 1995; 155: 277-81.
12. Mant J, Hobbs FD, Fletcher K et al. BAFTA investigators;Midlands Research Practices Network (MidRec). Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007; 370: 493-503.
13. Devereaux PJ, Anderson DR, Gardner MJ et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: Observational study. BMJ 2001; 323: 1218-22.
14. Dorian P, Paquette M, Newman D, Green MS, Talajic M, Roy D. Quality of life improves following treatment in Canadian Trial of Atrial Fibrillation. Circulation (Suppl I) 1999; 100: I-502.
15. Das AK, Willcoxson PD, Corrado OJ, West RM. The impact of long-term warfarin on the quality of life of elderly people with atrial fibrillation. Age Ageing 2007; 36: 95-7.
16. Ware JE, Sherbourne CD. TheMOS 36-item short form health survey. Conceptual framework and item selection. Med Care 1992; 30: 473-81.
17. Hayes V, Morris J, Wolfe C et al. The SF-36 health survey questionnaire: Is it suitable for use with older adults? AgeAgeing 1995; 24: 120-5.
18. Ware JE, Kosinski M, Turner-Bowker DM et al. How to score version 2 of the SF-12 health survey. ISBN: 1-891810-10-3, pp 88-91.
19. Hamilton LC. STATA statistics version 10. Cengage 2009, ISBN: 9780495557869.
20. Lancaster TR, Singer DE, Sheehan MA et al. The impact of long-term warfarin therapy on quality of life- the Boston Area Anticoagulation Trial for Atrial Fibrillation Investigation. Arch Intern Med 1991; 15: 1944-49.
21. Perera V, Bajorek BV, Matthews S et al. The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Ageing 2009; 38: 156-62.